Should low-dose aspirin also be a background therapy for all patients with systemic lupus erythematosus (SLE)?

Petri M . Hydroxychloroquine: past, present, future . Lupus 1998; 7: 65–67 .

Gladman DD , Urowitz MB , Senecal JL et al. Aspects of use of antimalarials in systemic lupus erythematosus . J Rheumatol 1998; 25: 983–985 .

Rich-Edwards JW , Manson JE , Hennekens CH , Buring JE . The primary prevention of coronary heart disease in women . New Engl J Med 1995; 332: 1758–1766 .

Abu-Shakra M , Urowitz MB , Gladman DD , Gough J . Mortality studies in systemic lupus erythematosus. Results from a single centre. I. Cause of death . J Rheumatol 1995; 22: 1259–1264 .

Manzi S , Meilahn EN , Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with Framingham study . Am J Epidemiol 1997; 145: 408–415 .

Cervera R , Khamashta MA , Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus . Medicine (Baltimore) 1999; 78: 167–175 .

Rahman P , Urowitz MB , Gladman DD , Bruce IN , Genest Jr. J . Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus . J Rheumatol 1999; 26: 2363–2368 .

Ramsey LE , Williams B , Jonston GD et al. British Hypertension Society guidelines for hypertension management 1999: summary . Br Med J 1999; 319: 630–635 .

Asherson RA , Piette J , Cervera R . ‘Primary’ , ‘secondary’ , ‘catastrophic’ , and other variants of the antiphospholipid syndrome. In: Asherson RA , Cervera R , Piette J , Shoenfeld Y (eds). The antiphospholipid syndrome. CRC Press: Boca Raton , 1996, 249–258.

Khamashta MA . Management of thrombosis and pregnancy loss in the antiphospholipid syndrome . Lupus 1998; 7 (Suppl 2): S162–S165 .

Lockshin MD . Lupus pregnancy loss and antiphospholipid antibodies . Lupus 1998; 7 (Suppl 2): S86–S89 .

Mont MA , Glueck CJ , Pacheco IH , Wang P , Hungerford DS , Petri M . Risk factors for osteonecrosis in systemic lupus erythematosus . J Rheumatol 1997; 24: 654–662 .

Glanz BI , Slonim D , Urowitz MB , Gladman DD , Gough J , MacKinnon A . Pattern of neuropsychologic dysfunction in active systemic lupus erythematosus . Neuropsychiatry Neuropsychol Behav Neurol 1997; 10: 232–238 .

Meyer JS , Rogers RL , McClintic K , Mortel KF , Lotfi J . Randomized clinical trial of daily aspirin therapy in multi-infarct dementia . A pilot study. J Am Geriatr Soc 1989; 37: 549–555 .

Thrift AG , McNeil JJ , Forbes A , Donnan GA . Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study . Br Med J 1999; 318: 759–764 .

Anonymous . Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial . Lancet 2000; 355: 1295–1302 .

Munoz-Rodriguez FJ , Font J , Cervera R et al. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome . Semin Arthritis Rheum 1999; 29: 182–190 .

Laskin CA , Bombardier C , Hannah ME et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent foetal loss . New Engl J Med 1997; 337: 148–153 .

Naschitz JE , Yeshurun D , Odeh M et al. Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease . Am J Gastroenterol 1990; 85: 408–411 .

Sanchez-Ojanguren J , Matias J , Misis M , Olive A . Systemic lupus erythematosus, berry aneurysm and subarachnoid haemorrhage . Clin Rheumatol 1999; 18: 165–166 .

Wahl DG , Bounameaux H , de Moerloose P , Sarasin FP . Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies . Arch Intern Med 2000; 160: 2042–2048 .